Skip to main content
Publications
Kurosky S, Levine C, Kaye JA, Esterberg E , Suarez LA, Zhan L, Iyer S. HR+/HER2− advanced breast cancer treatment, disease progression, and survival in Argentina, Brazil, Chile, Colombia, and Mexico . Poster presented at the 2018 ISPOR 21st Annual European Congress; November 14, 2018. Barcelona, Spain.
Fehnel S , Ervin C , McLeod L , Carson RT, Reasner D, Hanlon J, Eremenco S, Coons SJ, PRO Consortium’s Irritable Bowel Syndrome Working Group. Psychometric evaluation of the diary for irritable bowel syndrome symptoms-constipation (DIBSS-C) . Poster presented at the 2018 ISPOR 21st Annual European Congress; November 13, 2018. Barcelona, Spain.
Poulos C , Feldman SR, Gilloteau I, Boeri M, Guana A, Germino B, Boehm K, Gutknecht M, Augustin M. The most influential drivers of psoriasis patients' treatment choice: a discrete choice experiment survey in the US . Poster presented at the 2018 ISPOR 21st Annual European Congress; November 12, 2018. Barcelona, Spain.
Aletaha D, Husni ME, Merola JF, Ranza R, Bertheussen H, Lippe R, Young P, Cappelleri JC, Brown TM , Ervin C , Hsu M-A, Fallon L. Facilitating shared decision-making in psoriatic arthritis: factors influencing patient preference for treatment mode of administration . Poster presented at the 2018 ACR/ARHP Annual Meeting; October 23, 2018. Chicago, IL.
Taylor PC, Betteridge N, Brown TM , Woolcott J, Kivitz AJ, Zerbini CAF, Whalley D , Olayinka-Amao O , Chen C, Dahl P, Ponce de Leon D, Gruben D, Fallon L. Treatment modes in rheumatoid arthritis: moving toward shared decision making . Poster presented at the 2018 ACR/ARHP Annual Meeting; October 23, 2018. Chicago, IL.
Pladevall M , Pottegard A, Schink T, Reutfors J, Morros R, Poblador-Plou B, Timmer A, Forns J , Hellfritzsch M, Reinders T, Hagg D, Giner-Soriano M, Prados-Torres A, Cainzos-Achirica M, Hallas J, Kollhorst B, Brandt L, Cortes J, Aguado J , Perlemuter G, Falissard B, Castellsague J, Jacquot E, Deltour N, Perez-Gutthann S . Agomelatine and other antidepressants and the risk of acute liver injury (ALI), a post authorisation safety study (PASS) in four European countries . Poster presented at the 31st ECNP Congress; October 8, 2018. Barcelona, Spain. Previously presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Joish VN, Price MA , Schwartz S, Stanley S, Bennett L , Darden C , Tesfaye E, Mobley Q, Arnold K, Wason S, Lapuerta P. Xermelo patient registry: a real-world evidence study evaluating patient-reported outcomes with Xermelo . Poster presented at the 2018 NANETS Annual Multidisciplinary NET Disease Symposium; October 4, 2018. Seattle, WA.